Being invited to present research at an international academic conference is an honor for any seasoned professional. But for ...

Use of AI can be a controversial subject, but in many ways, it's improving patient's experiences and helping doctors detect ...

Cognizant CAIO Babak Hodjat on agentic AI, sovereign compute, and how India’s AI ecosystem can scale through infrastructure, design, and collaboration, interview ...

Artificial intelligence has moved from pilot projects to a central role in many life sciences strategies. What began as a set ...

Illumina, Inc. (NASDAQ: ILMN) today announced the launch of TruPath™ Genome, setting a new standard for high-quality, ...

People with aphantasia have no mental imagery—and they’re offering brain scientists a window into consciousness ...

Daily biometrics, smart scales and AI companions are quietly rewriting the rules of aging.

As of Friday, February 27, Fulgent Genetics, Inc.’s FLGT share price has dipped by 31.34%, which has investors questioning if this is right time to buy.

Rare disease is a major – and growing – area of clinical research and drug development. Of the FDA’s 46 novel drug approvals ...

SCARBOROUGH, ME / ACCESS Newswire / February 26, 2026 /Originally published on Guiding Stars Health & Nutrition News By Mark Kantor The Guiding Stars algorithms, the formulas used to assign Stars to ...